ECSP992840A - PROCEDURE TO TREAT HEART FAILURE - Google Patents
PROCEDURE TO TREAT HEART FAILUREInfo
- Publication number
- ECSP992840A ECSP992840A ECSP992840A ECSP992840A EC SP992840 A ECSP992840 A EC SP992840A EC SP992840 A ECSP992840 A EC SP992840A EC SP992840 A ECSP992840 A EC SP992840A
- Authority
- EC
- Ecuador
- Prior art keywords
- heart failure
- procedure
- treat heart
- phenoxy
- trimethyl
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 4
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- -1 1-ethyl-propoxy Chemical group 0.000 abstract 1
- VIZBSVDBNLAVAW-UHFFFAOYSA-N 3,6-dimethyl-n-pentan-3-yl-2-(2,4,6-trimethylphenoxy)pyridin-4-amine Chemical compound CCC(CC)NC1=CC(C)=NC(OC=2C(=CC(C)=CC=2C)C)=C1C VIZBSVDBNLAVAW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Esta invención se refiere a un procedimiento para el tratamiento de un mamífero que presenta insuficiencia cardiaca, que comprende administrar a un mamifero una cantidad terapéuticamente eficaz de 4-(1-etil-propoxi)-3,6-dimeti-2(2,4,6-trimetil-fenoxi)-piridina y (3,6 dimetil-2-(2,4,6 -trimetil-fenoxil-)-piridin-4-il)-(1-etil-propil)-amina o una sal farmacéuticamente aceptable de las mismas. Esta invención también se refiere a procedimientos para usar combinaciones de esos dos agentes con otros compuestos para el tratamiento de la isuficiencia cardiaca congestiva para tratar la insuficiencia cardiaca congestiva.This invention relates to a method of treating a mammal presenting with heart failure, comprising administering to a mammal a therapeutically effective amount of 4- (1-ethyl-propoxy) -3,6-dimethi-2 (2,4 , 6-trimethyl-phenoxy) -pyridine and (3,6-dimethyl-2- (2,4,6 -trimethyl-phenoxy -) - pyridin-4-yl) - (1-ethyl-propyl) -amine or a salt pharmaceutically acceptable thereof. This invention also relates to methods for using combinations of those two agents with other compounds for the treatment of congestive heart failure to treat congestive heart failure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992840 ECSP992840A (en) | 1999-01-26 | 1999-01-26 | PROCEDURE TO TREAT HEART FAILURE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992840 ECSP992840A (en) | 1999-01-26 | 1999-01-26 | PROCEDURE TO TREAT HEART FAILURE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992840A true ECSP992840A (en) | 1999-05-17 |
Family
ID=42043830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992840 ECSP992840A (en) | 1999-01-26 | 1999-01-26 | PROCEDURE TO TREAT HEART FAILURE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992840A (en) |
-
1999
- 1999-01-26 EC ECSP992840 patent/ECSP992840A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9900653A (en) | Method for treating heart failure | |
| MX9704793A (en) | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine. | |
| MXPA03006855A (en) | Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same. | |
| EA200300155A1 (en) | THERAPEUTIC COMBINATION OF THE CETR AND ATORVASTATIN INHIBITOR | |
| EA200100573A1 (en) | APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR, MATRIC METALLOPROTEINASE INHIBITOR, ANTI-TUMOR MEDICINE, AND OPTIONAL IRRADIATION AS A COMBINED METHOD OF TREATING THE NEO. | |
| AR013742A1 (en) | METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE | |
| DK1346041T3 (en) | Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease | |
| DK0950057T3 (en) | 3-pyridylene enantiomers and their use as analgesics | |
| BR9811099A (en) | Urokinase inhibitors | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| DK1294379T3 (en) | A novel use of deferiprone | |
| EA199800717A1 (en) | METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION | |
| DK0799618T3 (en) | Use of alpha1 adrenoreceptor antagonists in the manufacture of a drug for the prevention and treatment of cancer | |
| ECSP992840A (en) | PROCEDURE TO TREAT HEART FAILURE | |
| NO20032006D0 (en) | Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders | |
| ATE268170T1 (en) | USE OF SUMMERIC ACID OR SALTS THEREOF TO TREAT INSULIN RESISTANCE | |
| WO2001034546A3 (en) | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye | |
| ES2186153T3 (en) | SULFATE 5-ALFA-PREGNAN-3-BETA-OL-20-ONA FOR THE TREATMENT OF TUMORS AND CNS DISORDERS. | |
| MXPA01007031A (en) | Method of treating chronic cardiac disease. | |
| NO20091111L (en) | Use of R (+) - alpha- (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidine-methanol for the treatment of sleep disorders | |
| DE69734349D1 (en) | TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN | |
| MX9604692A (en) | Quinoxaline derivatives for treating tinnitus. | |
| RU94044487A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for male sterility treatment | |
| EA200400817A1 (en) | IDRAPARINUKS FOR TREATMENT AND SECONDARY PREVENTION OF CASES OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH THROMBOSIS OF DEEP VEINS | |
| GT200100066A (en) | HYPERTENSIVE AGENT AND ITS USE. |